Farmer's lung disease: Analysis of 75 cases
Autor: | David Rubal, Esteban Cano-Jiménez, Alejandro Veres, Rafael Golpe, Noemí Mengual, Luis Pérez de Llano, Irene Hernández Martín, Lidia Méndez, Olalla Castro-Añón, Pilar Sanjuán |
---|---|
Rok vydání: | 2017 |
Předmět: |
Adult
Male medicine.medical_specialty Gastroenterology 03 medical and health sciences 0302 clinical medicine Antigen Sensitization Antigen Risk Factors DLCO Internal medicine medicine Humans 030212 general & internal medicine Aged Retrospective Studies biology Farmer's lung business.industry Retrospective cohort study Environmental exposure Middle Aged Prognosis medicine.disease 030228 respiratory system Farmer's Lung Immunology Disease Progression biology.protein Female Seasons Antibody business Immunosuppressive Agents Hypersensitivity pneumonitis Follow-Up Studies |
Zdroj: | Medicina Clínica (English Edition). 149:429-435 |
ISSN: | 2387-0206 |
DOI: | 10.1016/j.medcle.2017.10.009 |
Popis: | Introduction Farmer's lung disease (FLD) is a common form of hypersensitivity pneumonitis possibly underdiagnosed in our midst. The aim of this study was to describe clinical characteristics, evolution and factors that influence the prognosis of patients with FLD. Patients and methods A retrospective study that included all patients diagnosed with FLD presenting an environmental exposure risk, a clinic, lung function and a compatible radiology, in which antigen sensitization was demonstrated and/or a concordant pathology. Results We selected 75 patients with FLD, 50 with acute or subacute form (ASF) and 25 with chronic form (CF). Forty-four percent of patients (n = 33) were diagnosed during the months of March and April, especially those with ASF compared to CF (52 vs. 28%; p = 0.0018). In the ASF group, DLco showed an improvement during follow-up ( p = 0.047). The determination of specific IgG antibodies was positive in 39 patients (78%) with ASF (44% of them against Aspergillus ) and CF 12 (48%). The realization of antigenic avoidance (OR 9.26, 95% CI 1.3–66.7, p = 0.026) and the administration of immunosuppressive therapy (OR 16.13, 95% CI 1.26–200, p = 0.033) were predictors of better disease progression. Conclusions FLD is predominantly seasonal in our environment. CF usually has a negative specific IgG antibodies unlike ASF, where antibodies against Aspergillus are the most common. The realization of antigenic avoidance and immunosuppressive treatment are possible predictors of better disease progression. |
Databáze: | OpenAIRE |
Externí odkaz: |